DivvyDiary
A dividend calendar and income forecast first, the portfolio second. Free for 1 portfolio, Aristokrat is €89.99 a year.
Everything in DivvyDiary leads back to the next payout. The core is a personal dividend calendar, forward estimates, a yearly income summary and the net amount after your tax rate and allowance. Holdings, cost basis and a performance chart sit underneath, and you can overlay that chart with any security as a benchmark. Trade Republic, Scalable Capital and Consorsbank sync directly, and everything else comes in by CSV. The free Sparfuchs plan holds 1 portfolio and asks for no payment details. Aristokrat costs €9.99 a month or €89.99 a year. Two things we couldn't find: a description of how the performance chart is calculated, and documentation for the API that Parqet already reads from.
Features at a glance
| Feature | DivvyDiary |
|---|---|
| Pricing | Freemium |
| Tracking & data | |
| Manual entry | Yes |
| CSV / broker import. Import holdings and transactions from broker or exchange CSV files. | Yes |
| Automatic bank/broker sync. Connects to your bank or broker to pull holdings in automatically. | Yes |
| Multi-asset | Yes |
| Multi-currency | Yes |
| Dividend tracking | Yes |
| Dividend/income forecast. Projects future dividend income and shows an income calendar. | Yes |
| Tax reports | Not supported |
| Analysis & insights | |
| AI portfolio analysis | Not supported |
| AI asset & market analysis. AI commentary on individual holdings and market context, not just the whole portfolio. | Not supported |
| Portfolio health score. A single score rating diversification, concentration and other portfolio-health signals. | Not supported |
| Rebalancing & drift. Shows how far your allocation has drifted from target and how to correct it. | Not supported |
| Goal & time-to-goal | Not supported |
| Custom groupings / tags. Group holdings by your own dimensions (e.g. strategy, theme), not just asset class. | Not supported |
| Return method (TWR/MWR). True time-weighted (TWR) and money-weighted (MWR/XIRR) return — not just a simple % change. | —Not verified |
| Benchmark & alpha. Compare returns against a benchmark, including alpha. | Yes |
| Backtesting & scenarios. Test a portfolio against historical data or run scenario simulations. | Partial |
| Access & pricing | |
| Free tier | Yes |
| No account linking required. Works without connecting a bank login or aggregator. | Yes |
| Open source | Not supported |
| Self-hostable | Not supported |
| Public API | Partial |
| Platform & reach | |
| Mobile app | Partial |
| Multi-language | Yes |
| Community & extras | |
| Public / social portfolios. Share your portfolio publicly and follow other investors. | Yes |
| AI portfolio roast. A shareable AI roast: a frank critique of a portfolio. | Not supported |
Best for
Dividend investors at German brokers who check the payout calendar more often than the share price. Skip it if you need targets, goals or a tax filing: DivvyDiary does none of these.
Strengths
- Dividend calendar, forward estimates and the net payout after tax rate and allowance
- Direct sync with Trade Republic, Scalable Capital and Consorsbank, CSV for the rest
- A free plan with no payment details, plus a public read-only portfolio link
Trade-offs
- The performance chart's calculation method isn't documented anywhere we looked
- No targets, rebalancing, goals or custom groupings
- Phone apps are wrapped web pages, and the free plan holds 1 portfolio
DivvyDiary vs PortfolioGlance
Dividend forecasts and direct sync with three German brokers are DivvyDiary's, and we lack both. If the next payment date is the number you check, it's the better tool. Outside dividends the roles flip: we measure returns time- and money-weighted with a stated method, show the drift from your target allocation and when you'll reach a goal, and keep property or deposits next to shares.
Try PortfolioGlance freeCompare with
Alternatives and rankings
This is our editorial review, not financial advice. Features and prices may have changed since we checked, so see the official site for the latest.